Catalyst Wire Dossier Catalyst Wire Dossier

Etokimab

· AnaptysBio, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Etokimab, covering 2022-01-24 to 2023-08-16. Get the full timeline:

Most recent: Clinical Trial Update: Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma [Phase 2]

See pricing